Breast reduction surgery and breast cancer risk: does reduction mammaplasty have a role in primary prevention strategies for women at high risk of breast cancer?

Plastic and Reconstructive Surgery
Robert E TaroneJoseph K McLaughlin

Abstract

Prophylactic bilateral mastectomy has been demonstrated to reduce breast cancer incidence in women with a high inherited susceptibility to breast cancer. For the majority of high-risk women, however, bilateral prophylactic mastectomy is not an acceptable option for primary prevention of breast cancer. Several epidemiological follow-up studies have indicated that there may be a substantial reduction in breast cancer risk among women who have undergone breast reduction surgery. The authors reviewed the evidence from these studies, with emphasis on the problems inherent in interpreting the results of nonexperimental studies of elective medical procedures. Although such observational studies cannot demonstrate definitively that reduction mammaplasty reduces the risk of breast cancer, the evidence from these studies is sufficiently strong to warrant the evaluation of breast reduction surgery as an option for primary prevention in clinical studies of women at increased risk of breast cancer. The availability of a more acceptable surgical option for primary prevention of breast cancer could increase the number of women willing to choose risk reduction surgery and thus may result in an overall reduction in breast cancer mortality among...Continue Reading

References

Jan 1, 1991·Aesthetic Plastic Surgery·L Hang-Fu
Jan 1, 1987·Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery·K LundG Schou
Sep 1, 1994·Pathology, Research and Practice·V Karabela-BouropoulouN J Agnantis
Apr 1, 1996·British Journal of Cancer·M BaaschK Lund
Oct 1, 1996·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·A TavaniS Franceschi
Mar 6, 1997·The New England Journal of Medicine·S E GabrielL J Melton
Dec 1, 1996·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·M Lipkin
Mar 1, 1997·Cancer Causes & Control : CCC·S Franceschi
Feb 14, 1998·Plastic and Reconstructive Surgery·D A JansenK Sands
Oct 17, 1998·Plastic and Reconstructive Surgery·R R White
Jan 14, 1999·The New England Journal of Medicine·A Eisen, B L Weber
May 14, 1999·Plastic and Reconstructive Surgery·M H BrownE Holowaty
May 14, 1999·Plastic and Reconstructive Surgery·C L TangE Holowaty
Apr 28, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A EisenB L Weber
Sep 6, 2001·Journal of the National Cancer Institute·M StefanekW Nelson
Jan 17, 2002·Journal of the National Cancer Institute·Gregory P Swanson
Jan 17, 2002·The New England Journal of Medicine·K OffitD Schrag
Mar 20, 2002·Clinical Breast Cancer·D K Blanchard, L C Hartmann
Apr 17, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mariëlle S van RoosmalenWillem A J van Daal
May 3, 2002·Journal of Clinical Pathology·V SpeirsP J Carder
Sep 27, 2002·The New England Journal of Medicine·Sen H ZhuangSandra M Swain
Oct 3, 2002·Nature Reviews. Cancer·Trevor J Powles
Oct 18, 2002·Lancet·Richard D KennedyD Paul Harkin
Dec 25, 2002·Epidemiology·Asa S JohanssonElisabeth Kylberg
Feb 5, 2003·Annals of Plastic Surgery·Charles E ButlerS Eva Singletary
Jul 3, 2003·Journal of the National Cancer Institute·Hester M KlarenMatti A Rookus
Aug 9, 2003·The New England Journal of Medicine·John Bailar
Mar 1, 1960·Plastic and Reconstructive Surgery and the Transplantation Bulletin·R K SNYDERMAN, J G LIZARDO

❮ Previous
Next ❯

Citations

Dec 3, 2014·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·L A JansenM H Brown
Feb 20, 2007·Clinics in Plastic Surgery·Louise J BordeleauPeter C Neligan
Oct 24, 2009·The Breast : Official Journal of the European Society of Mastology·Michael GreenJames Kollias
Mar 26, 2016·Clinics in Plastic Surgery·Grant W Carlson
Jan 27, 2005·Journal of Women's Health
Jul 25, 2006·Annals of Plastic Surgery·Marcos Desidério RicciJosé Aristodemo Pinotti
Feb 5, 2011·Archives of Gynecology and Obstetrics·Verena Engelstaedter, Ioannis Mylonas
May 25, 2006·Clinical Obstetrics and Gynecology·Karol A Gutowski
Sep 10, 2005·International Journal of Cancer. Journal International Du Cancer·Søren FriisJørgen H Olsen
Jan 21, 2021·Annals of Plastic Surgery·Peter DeptulaDung Nguyen
Nov 26, 2008·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·E J Majdak-Paredes, F Fatah

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.